Mari Miyamoto, PhD.
banner
marimiya-tky.bsky.social
Mari Miyamoto, PhD.
@marimiya-tky.bsky.social
General Manager APAC and Japan at Protein Metrics. Loves birds
photography.
Reposted by Mari Miyamoto, PhD.
Analyses of one of the world’s largest protein datasets offer new insights into the biological underpinnings of major neurodegenerative diseases, according to research presented by the Global Neurodegeneration Proteomics Consortium (GNPC) in Nature Medicine and Nature Aging. #medsky 🧪
Global Neurodegeneration Proteomics Consortium
The Global Neurodegeneration Proteomics Consortium is a multi-national database that aims to leverage proteomics and clinical data to understand and improve ...
go.nature.com
July 15, 2025 at 7:05 PM
Reposted by Mari Miyamoto, PhD.
Regeneron Genetics Center Launches Proteomics Study of 200K Geisinger Samples Using Olink Platform
Regeneron Genetics Center Launches Proteomics Study of 200K Geisinger Samples Using Olink Platform
www.genomeweb.com
June 12, 2025 at 8:27 PM
Reposted by Mari Miyamoto, PhD.
We've just launched AviList! - the new unified global taxonomic checklist for the world's birds, developed through the Working Group on Avian Classification, including BirdLife, Cornell Lab of Ornithology, IOC and others @birdlifeglobal.bsky.social @birdsoftheworld.bsky.social www.avilist.org
June 11, 2025 at 2:44 PM
Reposted by Mari Miyamoto, PhD.
Single-cell RNA sequencing data are often used as indirect estimates of protein abundance in single cells.

Instead, I think the goal should be to use the consistent discrepancies to understand regulatory mechanisms.

www.biorxiv.org/content/10.1...
June 7, 2025 at 4:53 PM
Reposted by Mari Miyamoto, PhD.
Marcin Czerwinski
Interesting review about glycoRNAs as immune regulators.
tinyurl.com/mvutz9ye

#glycotime
June 3, 2025 at 8:41 AM
Reposted by Mari Miyamoto, PhD.
Almost intentionally, looks like all of the new Thermo instrument pages are up (Astral Zoom, Excedion Pro, Optispray).
Overall vibes?
Excedion is the bigger upgrade, almost 2x faster and can now do ETD. Astral Zoom improvements are more incremental.
No change to instrument sensitivity specs.
May 28, 2025 at 11:04 AM
Reposted by Mari Miyamoto, PhD.
Too much protein in the diet appears to carry a risk of atherosclerotic heart disease secondary to leucine's effect. An important report considering recent advocacy for very high-protein diets.
@natmetabolism.nature.com
nature.com/articles/s42...
May 25, 2025 at 10:44 PM
Reposted by Mari Miyamoto, PhD.
Reposted by Mari Miyamoto, PhD.
Here's a key graph from that piece expanded
May 16, 2025 at 4:57 PM
Reposted by Mari Miyamoto, PhD.
“Americans die earlier and are sicker than people in other high-income countries. This has been true for a long time, and the trend is getting worse.”
gift link www.wsj.com/health/welln...
May 16, 2025 at 1:28 PM
Reposted by Mari Miyamoto, PhD.
Calling BS on this too
May 4, 2025 at 10:51 PM
Reposted by Mari Miyamoto, PhD.
Nature research paper: Histone H1 deamidation facilitates chromatin relaxation for DNA repair

https://go.nature.com/42iGjda
Histone H1 deamidation facilitates chromatin relaxation for DNA repair - Nature
Insights into how the linker histone H1 promotes chromatin alterations and allows repair of DNA damage are described.
go.nature.com
April 22, 2025 at 7:57 AM
Reposted by Mari Miyamoto, PhD.
With the #ASMS2025 app now available, here is a quick summary of what I've found so far from the abstracts:
Sciex - New ZenoTOF 8600, Echo-DMS
Thermo - New Exploris, New Astral (one of these is named Excedion), New OptiFlow source
Agilent - New single quad
Bruker - OmniTIMS, new triple quad, new LC
April 21, 2025 at 8:06 PM
Reposted by Mari Miyamoto, PhD.
Did you know? 99% of all new medications resulted from federally-funded university research through #NIH

Learn more about #ResearchSavesLives: hub.jhu.edu/research-sav....
April 16, 2025 at 8:31 PM
Reposted by Mari Miyamoto, PhD.
Thank you CBC for covering our latest study using
#proteomics and rapid patient derived models to inform patient care - out in EMBO Molecular Medicine.

A first in Canada step towards improved personalized #PrecisionMedicine

CBC: www.cbc.ca/player/play/...
Article: www.embopress.org/doi/full/10....
April 3, 2025 at 12:47 AM
Reposted by Mari Miyamoto, PhD.
High-throughput proteomics is helping us understand the biological basis (with causality) for diseases. Today for asthma
www.cell.com/cell-genomic... @markmccarthy985.bsky.social
Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity
Plasma proteomics may capture key insights into disease mechanisms and reveal informative biomarkers. Donoghue et al. apply a causal inference framework to genetic and plasma proteomic data from the U...
www.cell.com
April 4, 2025 at 9:37 PM
Reposted by Mari Miyamoto, PhD.
36,000 plasma proteomes by mass spectrometry? No nanoparticles?!?! 2,000 protein depth? Can NOT wait to read this. proteomicsnews.blogspot.com/2025/03/pca-...
PCA-N -36,000 human plasma proteomics samples by mass spec in 311 days!
WHOOOOOOOOOOOOOOOOOOOOOOOOOOOOOAAAAAAAA!!!!! Dataset for reanalysis alert!!  Mann lab optimized perchlorate based enrichment to get a supe...
proteomicsnews.blogspot.com
March 27, 2025 at 4:01 PM
Flew to Fukuoka for the Pharmaceutical Society of Japan meeting and caught a stunning view of Mt. Fuji from the plane. Despite all the yellow dust today, it was clear around Mt. Fuji. What an amazing sight!
March 26, 2025 at 4:01 AM
Reposted by Mari Miyamoto, PhD.
Genetic data giant 23andMe has filed for bankruptcy. What went wrong?

https://go.nature.com/4iDBili
What went wrong at 23andMe? Why the genetic-data giant risks collapse
At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.
go.nature.com
March 25, 2025 at 11:41 AM
Reposted by Mari Miyamoto, PhD.
The Protein Metrics website has a ton of cool stuff to support their different workflows. Also, cool if you just want to learn new stuff. #TeamMassSpec

www.proteinmetrics.com/resources
Using Byonic - Protein Metrics
The Byonic tutorial series covers MS/MS integration in Byos and Byosphere, optimizing peptide searches, interpreting search results, refining precursor charge, filtering PSMs, and generating peptide i...
www.proteinmetrics.com
March 21, 2025 at 2:43 PM
Reposted by Mari Miyamoto, PhD.
Awesome paper, where we present and evaluate the methodology that will someday enable real-time monitoring of circulating biomarkers. pubs.acs.org/doi/full/10....
Toward Real-Time Proteomics: Blood to Biomarker Quantitation in under One Hour
Multistep multihour tryptic proteolysis has limited the utility of bottom-up proteomics for cases that require immediate quantitative information. The power of proteomics to quantify biomarkers of health status cannot practically assist in clinical care if the dynamics of disease outpaces the turnaround of analysis. The recently available hyperthermoacidic archaeal (HTA) protease “Krakatoa” digests samples in a single 5 to 30 min step at pH 3 and >80 °C in conditions that disrupt most cells and tissues, denature proteins, and block disulfide reformation thereby dramatically expediting and simplifying sample preparation. The combination of quick single-step proteolysis with high-throughput dual-trapping single analytical column (DTSC) liquid chromatography–mass spectrometry (LC–MS) returns actionable data in less than 1 h from collection of unprocessed biofluid. The systematic evaluation of this methodology finds that over 160 proteins are quantified in less than 1 h from 1 μL of whole blood. Furthermore, labile Angiotensin I and II bioactive peptides along with a panel of protein species can be measured at 8 min intervals with a 20 min initial lag using targeted MS. With these methods, we analyzed serum and plasma from 53 individuals and quantified Angiotensin I and II and over 150 proteins including at least 46 that were not detected with trypsin. We discuss some of the implications of real-time proteomics including the immediate potential to advance several clinical and research applications.
pubs.acs.org
March 21, 2025 at 3:20 AM
Reposted by Mari Miyamoto, PhD.
An Australian man in his forties has become the first person in the world to leave hospital with an artificial heart made of titanium

The device could be a temporary measure for those waiting for a donor organ

https://go.nature.com/427bLLh
Man survives with titanium heart for 100 days – a world first
Nature - The device, to be tested in more people, could be used as a temporary measure for those waiting for a donor organ.
go.nature.com
March 16, 2025 at 5:38 PM
Reposted by Mari Miyamoto, PhD.
Exciting to share a new low-input proteomics technology for unbiased profiling cell surfaceome. The nanoMAPS miniaturizes bead-based AP-MS inside a single droplet, a key step in extending sensitive proteomics from global to functional measurement. www.biorxiv.org/content/10.1...
March 16, 2025 at 11:04 PM
Reposted by Mari Miyamoto, PhD.
Just out by Shelley Jager: rdcu.be/edEnO. One of the fastest & deepest plasma glycoproteomics studies. Take home message; we even detect glycosylated cytokines and chemokines, but also still need better software. #glycotime @utrechtuniversity.bsky.social @bijvoet-centre.bsky.social
In-depth plasma N-glycoproteome profiling using narrow-window data-independent acquisition on the Orbitrap Astral mass spectrometer
Nature Communications - While DIA has advanced standard proteomics, its application in glycoproteomics has remained limited. Here, the authors present an optimized narrow-window DIA method for...
rdcu.be
March 15, 2025 at 8:20 AM